# US 2025/0093241 A1 · Methods and systems for recovering assessable analytes from core needle biopsies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0093241 A1
- Document ID: US20250093241A1
- Status: Published application
- Kind: A1
- Application number: 18/468,416
- Filed: 2023-09-15
- Published: 2025-03-20
- Earliest claimed: 2023-09-15
- Assignees: Corramedical, Inc.
- Applicants: Corramedical, Inc.
- Inventors: Wilfrido MOJICA
- Web page: https://patentgrep.com/patent/US20250093241A1

## CPC

- G01N 1/34: Purifying; Cleaning {(processes or apparatus for extracting or separating nucleic acids from biological samples C12N15/1003)}
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12N 15/1017: {by filtration, e.g. using filters, frits, membranes}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G01N 1/4077: {by other techniques involving separation of suspended solids}
- G01N 2001/4088: {filtration}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Implementations include methods and systems for recovering an analyte from a tissue sample extracted via a core needle biopsy. The method may involve immersing the core needle holding the tissue sample in a sterilized buffer solution without formalin. Swirling of the needle may dislocate the tissue core and cells for creation of an intermediate mixture. This mixture may be filtered using a strainer into a sample tube to separate the tissue core resulting in another intermediate mixture. Equal volume of a cell lysis and stabilization reagent may be added to this mixture to yield a third mixture containing lysed dislodged cells. The assessable analyte, unexposed to formalin, may then be isolated. The system for this procedure may include a core needle, a buffer container, a sample tube, a strainer and a potential container for tissue core storage. The analyte could be DNA, RNA, an exosome, or a protein.

## Claims

### Claim 1

A method for recovering an assessable analyte potentially including DNA, RNA, an exosome or a protein from a tissue sample retrieved via a core needle biopsy, the method comprising:
providing a core needle having the tissue sample disposed therein retrieved via the core needle biopsy, wherein the tissue sample comprises a tissue core and dislodged cells;
providing a buffer solution, wherein the buffer solution does not comprise formalin;
immersing a portion of the core needle having the tissue sample disposed therein in the buffer solution;
swirling the core needle within the buffer solution to form a first intermediate mixture comprising the buffer solution, the tissue core, and the dislodged cells;
filtering the first intermediate mixture into a sample tube using a strainer to separate the tissue core from the first intermediate mixture, yielding the tissue core and a second intermediate mixture comprising the buffer solution and the dislodged cells;
adding a cell lysis and stabilization reagent not including formalin to the second intermediate mixture, yielding a third mixture comprising lysed dislodged cells from which the assessable analyte can be retrieved;
extracting the assessable analyte from the third mixture; and
assessing the assessable analyte;
wherein the assessable analyte has not been exposed to formalin.

### Claim 2 (depends on 1)

The method of claim 1, further comprising extracting the tissue core and disposing the tissue core within a container.

### Claim at position 3

3-9. (canceled)

### Claim 10

A method for recovering an assessable analyte potentially including DNA, RNA, an exosome or a protein from a tissue sample retrieved via a core needle biopsy, comprising:
providing a core needle having the tissue sample disposed therein retrieved via the core needle biopsy, wherein the tissue sample comprises a tissue core and dislodged cells;
immersing a portion of the core needle having the tissue sample disposed therein in a buffer solution;
swirling the core needle within the buffer solution to form a first intermediate mixture comprising the buffer solution, the tissue core, and the dislodged cells;
filtering the first intermediate mixture using a strainer into a sample tube to separate the tissue core from the first intermediate mixture, yielding the tissue core and a second intermediate mixture comprising the buffer solution and the dislodged cells; and
adding a cell lysis and stabilization reagent not including formalin to the second intermediate mixture yielding a third mixture comprising lysed dislodged cells from which the assessable analyte can be retrieved;
wherein the assessable analyte has not been exposed to formalin.

### Claim 11

(canceled)

### Claim 12 (depends on 10)

The method of claim 10, wherein the cell lysis and stabilization reagent is equal in volume to the second intermediate mixture.

### Claim 13 (depends on 10)

The method of claim 10, wherein the cell lysis and stabilization reagent comprises from 2 mL to 5 mL of the cell lysis and stabilization reagent.

### Claim 14 (depends on 10)

The method of claim 10, further comprising storing the sample tube having the third mixture disposed therein within a freezer.

### Claim 15 (depends on 14)

The method of claim 14, wherein the freezer operates to maintain an internal temperature of 4 deg C.

### Claim 16 (depends on 10)

The method of claim 10, further comprising extracting the assessable analyte from the third mixture.

### Claim 17 (depends on 10)

The method of claim 10, wherein the buffer solution comprises a phosphate buffered saline solution.

### Claim 18 (depends on 10)

The method of claim 10, further comprising sterilizing the buffer solution prior to immersing the core needle therein.

### Claim 19 (depends on 10)

The method of claim 10, wherein the assessable analyte is DNA, RNA, an exosome, or a protein.

### Claim 20

(canceled)

### Claim 21 (depends on 1)

The method of claim 1, wherein the buffer solution is a sterilized phosphate buffered saline solution.

### Claim 22 (depends on 1)

The method of claim 1, wherein the cell lysis and stabilization reagent is equal in volume to the second intermediate mixture.

### Claim 23 (depends on 1)

The method of claim 1, wherein the cell lysis and stabilization reagent comprises from 2 mL to 5 mL of the cell lysis and stabilization reagent.

### Claim 24 (depends on 1)

The method of claim 1, further comprising storing the sample tube having the third mixture disposed therein within a freezer.

### Claim 25 (depends on 1)

The method of claim 1, further comprising maintaining the freezer at an internal temperature of 4 deg C.

### Claim 26 (depends on 1)

The method of claim 1, wherein assessing the assessable analyte includes using a fluorometer.

### Claim 27 (depends on 1)

The method of claim 1, wherein assessing the assessable analyte includes using a spectrophotometer.

### Claim 28 (depends on 1)

The method of claim 1, wherein the assessable analyte is DNA, RNA, an exosome, or a protein.
